Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies. - Wikidata - wikimedia - TriplyDB

Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies.

Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies.

http://www.wikidata.org/entity/Q47936492

about

Proteomic-Based Approaches for the Study of Cytokines in Lung Cancer Therapeutic cancer vaccines: past, present, and future Cancer immunotherapy Lentiviral vector delivery of human interleukin-7 (hIL-7) to human immune system (HIS) mice expands T lymphocyte populations Innate and Adaptive Immune Regulation During Chronic Viral Infections Mechanism of Action of IL-7 and Its Potential Applications and Limitations in Cancer Immunotherapy Chemo-immunotherapy with oxaliplatin and interleukin-7 inhibits colon cancer metastasis in mice ARIH2 is essential for embryogenesis, and its hematopoietic deficiency causes lethal activation of the immune system CD27 stimulation promotes the frequency of IL-7 receptor-expressing memory precursors and prevents IL-12-mediated loss of CD8(+) T cell memory in the absence of CD4(+) T cell help.Cytokines as Adjuvants for Vaccine and Cellular Therapies for Cancer.Naive tumor-specific CD4(+) T cells differentiated in vivo eradicate established melanoma.Systemic administration of TLR3 agonist induces IL-7 expression and IL-7-dependent CXCR3 ligand production in the lung.Chemotherapy rescues tumor-driven aberrant CD4+ T-cell differentiation and restores an activated polyfunctional helper phenotype.Maturation of monocyte derived dendritic cells with OK432 boosts IL-12p70 secretion and conveys strong T-cell responses.Aberrant plasma IL-7 and soluble IL-7 receptor levels indicate impaired T-cell response to IL-7 in human tuberculosis.Memories that last forever: strategies for optimizing vaccine T-cell memory.Redirecting the immune response: role of adoptive T cell therapy.Abrogating Cbl-b in effector CD8(+) T cells improves the efficacy of adoptive therapy of leukemia in mice.Regulation of in vitro human T cell development through interleukin-7 deprivation and anti-CD3 stimulation Interleukin-7, but not thymic stromal lymphopoietin, plays a key role in the T cell response to influenza A virus.Endogenous T cell responses to antigens expressed in lung adenocarcinomas delay malignant tumor progression.NLRP1 inflammasome activation induces pyroptosis of hematopoietic progenitor cells.Phenotype, distribution, generation, and functional and clinical relevance of Th17 cells in the human tumor environments.Immunotherapeutic effects of IL-7 during a chronic viral infection in mice.Peptide-pulsed dendritic cells have superior ability to induce immune-mediated tissue destruction compared to peptide with adjuvant IL-6 promotes acute and chronic inflammatory disease in the absence of SOCS3.Interleukin-7 inhibits tumor-induced CD27-CD28- suppressor T cells: implications for cancer immunotherapy.T(H)17 cells in tumour immunity and immunotherapy.Loss of the signaling adaptor TRAF1 causes CD8+ T cell dysregulation during human and murine chronic infection Immunomodulatory and anticancer potential of Gan cao (Glycyrrhiza uralensis Fisch.) polysaccharides by CT-26 colon carcinoma cell growth inhibition and cytokine IL-7 upregulation in vitro.IL-7 receptor blockade reverses autoimmune diabetes by promoting inhibition of effector/memory T cells.IL-7 receptor α blockade, an off-switch for autoreactive T cells.Broad induction of immunoregulatory mechanisms after a short course of anti-IL-7Rα antibodies in NOD mice.Anti-viral CD8 T cells and the cytokines that they love Immunoregulation of hepatitis B virus infection--rationale and clinical application Interleukin-7 enhances the Th1 response to promote the development of Sjögren's syndrome-like autoimmune exocrinopathy in mice Interdependent IL-7 and IFN-γ signalling in T-cell controls tumour eradication by combined α-CTLA-4+α-PD-1 therapy.Forced co-expression of IL-21 and IL-7 in whole-cell cancer vaccines promotes antitumor immunity.Activin receptor-like kinase5 inhibition suppresses mouse melanoma by ubiquitin degradation of Smad4, thereby derepressing eomesodermin in cytotoxic T lymphocytes.The polarization of immune cells in the tumour environment by TGFbeta.

P2860

Q26738539-95C52FE9-3D67-41E7-8A46-3C1511B3EE9B Q26863283-259E2866-625B-44C1-A086-CCA2D28FAA7D Q27026870-A2437677-0FE6-4E1F-A028-5DB6610B7B9F Q27322228-D726D488-E19B-4B05-9ABE-59DBF8AC6119 Q28079717-EDC0911A-DA70-4F2D-AAE2-4E6EB6798197 Q28084138-764B9F16-17E0-4B82-AA11-64A3E3B525F9 Q28538913-009DC5DE-788C-487B-8554-D068F33AFBEB Q28593507-D3245EF8-6CC1-4A83-897B-63428B01E2A3 Q30419978-73D69D8C-4B09-4520-98D9-6CE159BDD409 Q33680566-CC80CDD9-AE92-4781-91C0-7C2965ED977F Q33730129-64A33FB4-A609-4CAC-8242-FF1796390A6B Q33730296-5D1689F2-8A76-4AC0-ADCA-D08DE4B4899C Q33754618-A6B601C4-93FD-4C5D-9556-D90119800F26 Q33786246-11F8DCD6-B1FC-42A5-80F4-85887D561C68 Q33803416-7650529B-AE43-4AF9-8088-568AF2DFEF8F Q34060493-BEBDDD04-73C3-4565-901C-CAAC8134EE28 Q34123238-0ADB820E-13C6-413A-9121-7C6F9FE07EAA Q34162136-4E03F390-5AF0-4608-BA1F-B0EEF01DC709 Q34381798-E5CC4601-50E4-4B17-A873-51F9D14892F3 Q34494025-45622955-9E32-407F-B70B-4FBA584D817D Q34755544-71C1A920-19BF-4CE3-B0C9-05DBDFF90347 Q34764912-7A443944-01DD-4442-B7D5-97BC1E905F32 Q34983123-E2EA6FBA-B3B7-4577-AD6E-77482F63D1C9 Q35029432-EE798C44-D507-4B47-8B09-E033A2BC8C90 Q35125382-B5C8B634-E6C6-469B-AEE8-803E24F8948A Q35137626-BCE916EB-C1DE-4BA0-8086-53DBBCA79AC1 Q35146532-EE65BA89-AC50-4E6F-B44E-23AC733D1256 Q35623903-E57D52DD-B11F-455E-A917-99A8307B939E Q35679587-DC872B5E-0E97-4BA4-BC42-AF60C4D25E95 Q36073299-F6F4ACD8-84F6-4111-BC7F-ECAEDF48B2E7 Q36140226-353521E6-78BC-4B4E-A76B-92589CB81131 Q36140521-AD9F281F-7E0C-4DBA-AB84-6FC629752DE2 Q36327212-DD89C308-353A-4326-AA5C-E92B2D7013AF Q36634580-3C730FCF-FCDF-4AE3-A1F2-CBBD140A8DC9 Q36797085-870166C7-5130-4C9C-8DA6-E66014981C0F Q37060371-62CF133A-1473-4DAE-86E5-D5AE6984EA4B Q37163445-71F3ADA2-AFA6-4390-AD91-66293F8A070B Q37215615-DCB605B2-CEAD-456A-AA47-499FD1A85CDD Q37342839-CAB2C16A-7C6D-4CE4-8EAE-E2EEC684E92E Q37454364-9B29D6C2-6CDF-4475-A678-4DE9B28CBBC3

P2860

Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies.

http://www.wikidata.org/entity/Q47936492

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh-hant

name

Adjuvant IL-7 antagonizes mult ...... ks to enhance immunotherapies.

@en

Adjuvant IL-7 antagonizes mult ...... ks to enhance immunotherapies.

@nl

type

label

Adjuvant IL-7 antagonizes mult ...... ks to enhance immunotherapies.

@en

Adjuvant IL-7 antagonizes mult ...... ks to enhance immunotherapies.

@nl

prefLabel

Adjuvant IL-7 antagonizes mult ...... ks to enhance immunotherapies.

@en

Adjuvant IL-7 antagonizes mult ...... ks to enhance immunotherapies.

@nl

P1433

Q47936492-3F2FF91C-778A-41BD-818C-04429E0ABCB9

P1476

Q47936492-CC851E58-D6E5-4141-959A-20A545643E9E

P2093

Q47936492-1188D2B0-7FAF-4752-816C-5FAF4E313B25

Q47936492-292DC63A-9530-4E88-A79B-17595917CE60

Q47936492-4E7F1B0C-BAD5-426B-99C0-69D7E5A1BC66

Q47936492-576FD2D7-545A-4B43-B066-9674054DEE22

Q47936492-713108E3-9AF6-4ABC-8182-DE5D720355BF

Q47936492-78F8D1AD-423B-43D2-96CD-77D64BD972F3

Q47936492-98CD4D81-A928-4DAD-A7A6-E2A279298DA0

Q47936492-AEEBB961-D4E2-4452-9D54-E6990FD1B303

Q47936492-BA06C9C9-1507-4107-8097-58888BB2D488

Q47936492-BE4075ED-6DBD-4715-8931-A462533E6988

P2860

Q47936492-0033C09F-EDD3-4FFE-B083-5AAF110AECA1

Q47936492-3723F4F8-B35E-4DA4-A68B-6AF1B2ECD2B1

Q47936492-602FCF0A-791E-44A4-AD51-28BB12D7E340

Q47936492-E68E2EBB-BF63-4100-AE3C-298179925D38

P2888

Q47936492-A4C92323-7373-41AB-84AF-9D66B7A848A3

P304

Q47936492-DF252E81-FDE5-4DBF-8189-0253DAD2939C

P31

Q47936492-BFC3EC2A-CAB6-467C-B645-15B35B6321E6

P356

Q47936492-F56372AD-1156-49F7-ACAB-65DCCA848130

P407

Q47936492-B8793362-E38F-4157-8853-AA1F45C4262B

P433

Q47936492-AE044C69-AC50-4580-B379-071C67077355

P478

Q47936492-141E80A1-1027-4CBC-A1EC-5511A39FABC8

P50

Q47936492-52440B83-C5D0-41C5-8B3A-45F362B73149

Q47936492-936709AD-2752-4636-BF9D-90901562685E

Q47936492-9BA05103-D545-4630-BE91-69BC0DF2D91C

P577

Q47936492-EFA38391-4E3E-4731-8863-17B0C6B100CC

P5875

Q47936492-2D755A06-0215-41EA-993E-7D5E1D0E6AE3

P698

Q47936492-B479EA72-EB6E-4A8F-A05C-A910B504310C

P921

Q47936492-8B69A7BF-A17C-4D25-BE46-5FE0AA4D2ED5

P356

P1433

Nature Medicine

P1476

Adjuvant IL-7 antagonizes mult ...... ks to enhance immunotherapies.

@en

P2093

Alisha R Elford

http://www.w3.org/2001/XMLSchema#string

Amy E Lin

http://www.w3.org/2001/XMLSchema#string

Arda Shahinian

http://www.w3.org/2001/XMLSchema#string

Brigitte Assouline

http://www.w3.org/2001/XMLSchema#string

Dilan Dissanayake

http://www.w3.org/2001/XMLSchema#string

Katharina Lahl

http://www.w3.org/2001/XMLSchema#string

Linh T Nguyen

http://www.w3.org/2001/XMLSchema#string

Matthew A Gronski

http://www.w3.org/2001/XMLSchema#string

Michel Morre

http://www.w3.org/2001/XMLSchema#string

Salim Dhanji

http://www.w3.org/2001/XMLSchema#string

P2860

Cutting Edge: Limiting amounts of IL-7 do not control contraction of CD4+ T cell responses

IL-7 inhibits fibroblast TGF-beta production and signaling in pulmonary fibrosis

Cutting edge: deficiency in the E3 ubiquitin ligase Cbl-b results in a multifunctional defect in T cell TGF-beta sensitivity in vitro and in vivo.

Resistance to CD4+CD25+ regulatory T cells and TGF-beta in Cbl-b-/- mice.

P2888

P304

528-536

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/NM.1953

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Pamela S Ohashi

Marc Pellegrini

P577

2009-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24361814

http://www.w3.org/2001/XMLSchema#string

P698

19396174

http://www.w3.org/2001/XMLSchema#string

P921